Researchers from Inserm and the University of Paris are launching this Monday, April 27, a national number, AlloCOVID, intended to " inform and ensure real-time monitoring of the epidemic thanks to artificial intelligence ", seven days a week. seven and 24 hours a day.
Read also: Deconfinement: tracking down without giving up public freedoms, the hard equation
People over 15 years of age wishing to check whether their health profile or state requires special attention can now contact AlloCOVID on 0 806 800 540 at the cost of a normal call, "as many times as their condition requires, " says a communicated. " They will then be put in contact with an" intelligent "virtual agent, capable of synthesizing the medical information transmitted and guiding them on their susceptibility to being reached or not by the Covid-19 ", he adds, adding that the service was " free" By analyzing the responses, the artificial intelligence will guide the caller after an average of 3 minutes. He can advise to call 15, a general practitioner, or to remain confined at home. The digital assistant is also able to " detect the signs of severity of the disease, as well as vulnerable patients requiring special attention ," he said.
Read also: A tracking app against the Covid-19: digital between fantasy and acceptance
This device also makes it possible to optimize the collection of data to ensure real-time monitoring of the epidemic everywhere in France, DOM-COM included, adds the press release, in particular to " support the release from confinement and detect immediately potential outbreaks of resurgence, in a synergistic and complementary way to existing systems (maladiecoronavirus.fr, SOS doctors, Sentinel network, etc.) centralized by Public Health France ", and to whom all the data collected by AlloCOVID will be communicated daily" anonymized ”.
Read also: Mobile tracking: how it works
In accordance with CNIL recommendations, this project was supported by data protection specialists while " the visualization and analysis of the data collected will be ensured through collaboration between Inserm and e.Voyageurs SNCF ", a subsidiary of the SNCF.
Read also: The Stop Covid app already criticized by many researchers
AlloCOVID was made available to SAMU-78 and tested for seven days during the month of April, before being extended to the national territory from this Monday.
Allo Covid wants to be a less intrusive alternative to the other application, StopCovid, which aims to trace its users by geolocation. This plan to open the Stop Covid application to the public will be the subject of a debate at the National Assembly tomorrow, Tuesday April 28.